615.1 — Фармация. Аптечное дело

Real-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in Japan Naoko Sanno, Kevin Y. Urayama, Joji Mori, Kenichi Yoshizawa, Chie Hashimoto · 2026

Critical analysis of withdrawn drug applications in marketing authorization procedures of the European Medicines Agency (EMA) 2006–2024 Florian Hitsch, Roland Seifert · 2026

Biomedical Large Language Models and Prompt Engineering for Causality Assessment of Individual Case Safety Reports in Pharmacovigilance Nicole Sonne Heckmann, Despoina Georgia Papoutsi, María Antonietta Barbieri, Vera Battini, Soren Norlin Molgaard · 2026

ПРЕДПРИНИМАТЕЛЬСТВО В ОБРАЗОВАНИИ ФАРМАЦИИ: НОВАЯ ПАРАДИГМА ПОДГОТОВКИ СПЕЦИАЛИСТОВ Файзуллаева Хурлиман Куатовна · 2025

ПРИМЕНЕНИЕ ЦВЕТКОВ CARTHAMUS TINCTORIUS L. (САФЛОРА КРАСИЛЬНОГО) В ФАРМАЦИИ Ризаева Нилуфар Мухутдиновна, Бахриддинова Дилноза, Арипова Нозима Хакимжановна · 2024

Стандартизация в фармации как индикатор развития экономики медицины Погребинская Е. А., Гегечкори В. И., Петричева А. С. · 2025

КАЧЕСТВО ОБСЛУЖИВАНИЯ НАСЕЛЕНИЯ В АПТЕКАХ МОГИЛЕВСКОГО РУП «ФАРМАЦИЯ» Н. В. Иванчикова, Е. А. Романенко · 2024

Efficacy and safety of cell-based therapies for drug-resistant epilepsy: a systematic review of human studies Amirali Latifian, Javad Akhondian, Farah Ashrafzade, Narges Hashemi, Arshia Khalesi · 2026

Web questionnaire survey of physicians and patients on the side effects of trifluridine/tipiracil Takako Eguchi Nakajima, Ryota Okude, Takuma Tone, Ayako Oshika, Ayako Yokomizo · 2026

Research progress of biological processing of traditional Chinese medicine:fermentation and sprouting Jia-Qi Shi, Xiao-ting Wang, Jia-li Tian, Yu Shi, Wang Ya-zhu · 2026

Reply to: Re‐Examining Sedative and Hypnotic Prescribing Following Hip Fracture Meng Pan, Elyse M. Miller, Qoua L. Her, Virginia Pate, K. Faurot · 2026

Diagnosis of acetaminophen and codeine poisoning in a dog using earwax analysis by headspace gas chromatography-mass spectrometry (HS/GC-MS) Monica Chacon de Vicente, Alexandre Có Mangoni Barros, Gabriela Scarpin de Souza, L Junqueira de Almeida Prado, João Marcos G. Barbosa · 2026

Historical evolution and molecular mechanisms of antimalarial drug resistance with emerging challenges and future directions Osazuwa John Patrick, Adewale Allen Sokan‐Adeaga, Rachael Olaide Emmanuel · 2026

Alternative Clinical Careers for Physicians: A Mentor-Focused Study of Medical Science Liaison Career Awareness During a Wilderness Medicine Program in Chamonix-Mont-Blanc, France S. S. Dyer, Richard Ingebretsen, Jeff Kraemer · 2026

How to Flourish during the Menopausal Transition: A Scoping Review on Emotional, Social and Psychological Wellbeing Isabelle F Klukas, Marijke Schotanus-Dijkstra · 2026

A randomized controlled trial of adjunctive speleotherapy in asthma, COPD and long COVID Joachim Schwarz, Madelaine Eicke, Nina Schwedler, Gerrit von Komorowski, Verena Goldfuss · 2026

Effects of a cardiac rehabilitation program on anthropometric and functional parameters: an observational pre-post study Estrella García-Sánchez, Mirian Santamaría-Peláez, Jerónimo J. González-Bernal, Josefa González‐Santos, Jessica Fernández-Solana · 2026

A retrospective analysis of gastrointestinal adverse events associated with nicorandil using the FDA Adverse Event Reporting System (FAERS) following STROBE guidelines Chen Chen, Daying Long, Yunhong Lei, Luhuan Yang, Rong Zhang · 2026

Artificial Intelligence in Pharmacovigilance: Revolutionizing Drug Safety Monitoring Through Machine Learning and Natural Language Processing Sachin Sharma, Harsh Goswami, Birender Singh, Reenu Chauhan, KM Nisha · 2026

Dysesthesia associated with GLP-1 agonist therapies: data-mining analysis and literature review Marie-Laure Laroche, Hélène Geniaux, Manon Jardou · 2026

Antibiotic-Induced Pulmonary Fibrosis: National Database Analysis О. И. Бутранова, Yury Kustov, Anna Abramova, Sergey Zyryanov, Irina Asetskaya · 2026

Beyond the Expected: Rare Immune-Related Neuromuscular Toxicities of Checkpoint Inhibitors—A Real-World Experience M. Vyas, Satyam Patel, Manasi Shah, Vruddhi Patel, Akshar Naik · 2026

Safety and Effectiveness of Guanfacine Hydrochloride Extended-Release in Adult Patients with ADHD in Japan: A Post-Marketing Surveillance Study Akira Iwanami, Katsuaki Shirai, Hiroyuki Ida · 2026

Exploring Microbiota-Based Interventions for Different System Diseases: Adjuncts to Targeted Pharmaceutical Therapies Desiree Virginia Fermin Olivares, Tyler Halverson, Kannayiram Alagiakrishnan · 2026

Evaluating the effectiveness of motivational interviewing techniques on medication adherence in patients with glaucoma: A systematic review Bintu Mohammed Lamba, Mustapha Bature · 2026

Evaluation of time to first adverse drug reaction among treatment-experienced adult persons living with HIV/AIDS: a retrospective cohort study Erick Wesley Hedima, Adamu Umar Abubakar · 2026

Quality of adverse drug reaction reports submitted to the national pharmacovigilance center of Nepal: a pre- and post-training evaluation Sushil Nepal, Shyam Shah, Narayan Prasad Dhakal, Umanga Tripathee, Santusta Adhikari · 2026

Gastrointestinal manifestations of systemic lupus erythematosus (SLE): A comprehensive literature review Wojciech Bajurny, Julia Grabowska, Amelia Pielech, Natalia Struzik, Jakub Mastalerz · 2026

Probiotics in the Prevention and Management of Antibiotic-Resistant Infections Mahdi Marzi, Ayşe Karacalı Tunç · 2026

Reducing Inappropriate Polypharmacy Ian Scott, Sarah N. Hilmer, Emily Reeve, Kathleen N. Potter, David G. Le Couteur · 2015

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics Sabué Mulangu, Lori E. Dodd, Richard T. Davey, Olivier Tshiani Mbaya, Michael A. Proschan · 2019

Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli · 2021

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome Orrin Devinsky, J. Helen Cross, Linda Laux, Eric D. Marsh, Ian Miller · 2017

2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz, Victor Aboyans, Riccardo Asteggiano · 2016

Interventional strategies for pulmonary arterial hypertension: Current perspectives and future directions Konstantinos Platanias, Stergios Soulaidopoulos, Marios Sagris, Athanasios Makris, Sofia Touriki · 2026

Levofloxacin versus moxifloxacin in nitazoxanide-based quadruple therapy as a first-line treatment for Helicobacter pylori infection: NILE, a randomized, comparative, multicenter study Gasser El-Azab, Sherief Abdel Salam, Ehab Moustafa, Ahmed Abuoelhassan, Ayman Shamseya · 2026

Adverse Drug Reaction Costs and Study Quality in Africa: A Systematic Review of Cost-of-Illness Studies Bezie Kebede, Bereket Bahiru, Chernet Tafere · 2026

Hypotensive Events Associated With PDE-5 Inhibitors in Pulmonary Arterial Hypertension: Assessment of the USFDA Adverse Event Reporting System Using Disproportionality and Interaction Analysis Kannan Sridharan, Gowri Sivaramakrishnan · 2026

From postmortem to pre-emptive: a framework for genomic integration within the UK Yellow Card scheme Michael Wahba · 2026

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz, Victor Aboyans, Riccardo Asteggiano · 2016

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors Daniel Wang, Joe‐Elie Salem, Justine V. Cohen, Sunandana Chandra, Christian Menzer · 2018

Revolutionizing healthcare: the role of artificial intelligence in clinical practice Shuroug A. Alowais, Sahar S. Alghamdi, Nada Alsuhebany, Tariq Alqahtani, Abdulrahman Alshaya · 2023

The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety Martins Ekor · 2014

The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement Eric I. Benchimol, Liam Smeeth, Astrid Guttmann, Katie Harron, David Moher · 2015

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson · 2018

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care Marc D. Binder, Christoph U. Correll, Julio Bobes, Marcelo Cetkovich, Dan Cohen · 2011

Pharmacovigilance of semaglutide: A descriptive analysis of WHO-VigiAccess reports Nasser M. Alorfi, Mansour M. Alourfi, Ammar AlDabbagh, Waleed Saleh Alghamdi, Sarah S. Al Ghamdi · 2026

Consensus statement on the application of artificial intelligence in osteoporosis screening and management: perspectives from the Asia-Pacific region Chun‐Feng Huang, Wen-Hui Fang, Kun-Hui Chen, Sung-Yen Lin, C K Ho · 2026

Age‐Dependent Cardiovascular Adverse Event Reporting With Pathway‐Directed Anticancer Therapies in Children and Adults: A VigiBase Disproportionality Analysis Fabien Labombarda, Damien Bodet, Jérémie Rouger, C Guerin, Marion Sassier · 2026

Modern Therapeutic Strategies in Rheumatoid Arthritis AND Other Autoimmune Diseases A. G. (Abduganieva) qizi · 2026

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update Bryan J. Schneider, Jarushka Naidoo, Bianca D. Santomasso, Christina Lacchetti, Sherry Adkins · 2021

Molecular Docking: Shifting Paradigms in Drug Discovery Luca Pinzi, Giulio Rastelli · 2019

The Traditional Medicine and Modern Medicine from Natural Products Hai-Dan Yuan, Qianqian Ma, Ye Li, Guangchun Piao · 2016

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews Matthew J. Page, David Moher, Patrick M. Bossuyt, Isabelle Boutron, Tammy Hoffmann · 2021

Pharmacological interventions for somatoform disorders in adults Maria Kleinstäuber, Michael Witthöft, Andrés Steffanowski, Harm van Marwijk, Wolfgang Hiller · 2014

Sustained Hematological Stability During Clozapine Rechallenge With Adjunctive Lithium: A Case Report of 15-Month Follow-Up Karim Hamda, Azeddine Barkiat, Siham Belbachir, Abderrazzak Ouanass · 2026

COMPLIANCE WITH JNC-8 GUIDELINES IN ANTIHYPERTENSIVE PRESCRIBING: EVIDENCE FROM A SOUTHERN NIGERIAN TERTIARY HOSPITAL Samuel Emeka O. Chukwuma · 2026

Evidence synthesis methods for overcoming data scarcity in child health research: a focus on antiemetic medications for preventing chemotherapy-induced nausea and vomiting in children Ruth Walker · 2026

TaIlored ManagEment of Sleep (TIMES) for people with dementia and mild cognitive impairment in primary care in England: protocol for a feasibility cluster-randomised controlled trial Jayden van Horik, Louise Allan, Aidin Aryankhesal, Niall M. Broomfield, P Greenstreet · 2026

Концепция пациентоориентированности в медицине и фармации Хохлов Александр Леонидович, Сычев Дмитрий Алексеевич · 2023

СУЛЬФОЛИТОХОЛЕВАЯ КИСЛОТА: ПЕРСПЕКТИВЫ ИСПОЛЬЗОВАНИЯ В ВЕТЕРИНАРНОЙ ФАРМАЦИИ Понамарёв В. С. · 2024

ИСПОЛЬЗОВАНИЕ НАГЛЯДНО-ДЕМОНСТРАЦИОННЫХ И ПРОБЛЕМНО-ПОИСКОВЫХ МЕТОДОВ ОБУЧЕНИЯ НА ЗАНЯТИЯХ ПО УЧЕБНОМУ ПРЕДМЕТУ «ОРГАНИЗАЦИЯ И ЭКОНОМИКА ФАРМАЦИИ» Карпенко О. В. · 2023

АКТУАЛЬНЫЕ АСПЕКТЫ ПЕРВИЧНОЙ АККРЕДИТАЦИИ СПЕЦИАЛИСТОВ ФАРМАЦИИ: ОПЫТ И ПРАКТИКА ТЮМЕНСКОГО ГОСУДАРСТВЕННОГО МЕДИЦИНСКОГО УНИВЕРСИТЕТА Родина Юлия Сергеевна, Викулова Ксения Анатольевна, Черкасова (бышенко) Виктория Владимировна, Русакова Ольга Александровна · 2025